Lupin receives Form 483 with 3 observations from USFDA for Pithampur Unit-3

The U.S. FDA inspected Lupin's Pithampur Unit-3 manufacturing facility from July 07 to July 17, 2025. The inspection closed with the issuance of a Form-483 with three observations.

We will address the observations and collaborate with the U.S. FDA to resolve them within the stipulated timeframe. We are committed to be compliant with CGMP quality standards across all our facilities.

Shares of Lupin Limited was last trading in BSE at Rs. 1955.35 as compared to the previous close of Rs. 1929.75. The total number of shares traded during the day was 11484 in over 870 trades.

The stock hit an intraday high of Rs. 1961.10 and intraday low of 1938.70. The net turnover during the day was Rs. 22398232.00.

Source : Equity Bulls

Keywords

Lupin INE326A01037 Pharmaceuticals Pithampur Unit3 USFDA Form483 3Observations